Answers are grounded in this paper and cite their sources.
A simple 6 variable clinical score may be used to guide use of PYP and increase recognition of ATTR-CM among patients with HFpEF in the community. Further validation in larger and more diverse populations is needed.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: